Clinical Trials for Bionoxx

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Bionoxx

Clinical Trials (2)

NCT07170592
A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients
PHASE1Not yet recruiting
24 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2030
1 condition1 sponsor0 locations
NCT07190833
A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)
PHASE1Not yet recruiting
27 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2030
1 condition1 sponsor0 locations